IRIS
FORNARO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 931
EU - Europa 271
AS - Asia 46
OC - Oceania 2
SA - Sud America 2
Totale 1.252
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 928
SE - Svezia 127
IT - Italia 69
CN - Cina 26
FR - Francia 25
GB - Regno Unito 19
DE - Germania 14
BE - Belgio 11
IN - India 8
VN - Vietnam 4
CA - Canada 3
IR - Iran 3
AU - Australia 2
FI - Finlandia 2
JP - Giappone 2
AR - Argentina 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
GF - Guiana Francese 1
KR - Corea 1
RO - Romania 1
SG - Singapore 1
TH - Thailandia 1
Totale 1.252
Salva come PNG Salva come JPEG
Città #
Chandler 170
Fairfield 114
Nyköping 114
Ashburn 65
Cambridge 49
Houston 49
Woodbridge 43
Seattle 40
Wilmington 36
Ann Arbor 27
Lawrence 26
New York 22
Roxbury 18
Inglewood 17
Beijing 14
Bari 13
Des Moines 13
Brussels 11
Princeton 9
London 6
Paris 6
Redwood City 6
Pune 5
Dong Ket 4
Nanjing 4
San Diego 4
Trani 4
Brooklyn 3
Florence 3
Hebei 3
Leawood 3
Naples 3
San Francisco 3
San Mateo 3
Toronto 3
Ardabil 2
Brindisi 2
Dearborn 2
Los Angeles 2
Massa 2
Monmouth Junction 2
Mumbai 2
Prescot 2
Saint-Fons 2
Verdellino 2
Augusta 1
Berlin 1
Bitonto 1
Brugherio 1
Campo San Martino 1
Canberra 1
Esslingen am Neckar 1
Greenwich 1
Haikou 1
Hat Yai 1
Helsinki 1
Hounslow 1
Jacksonville 1
Kilburn 1
Madrid 1
Melbourne 1
Milan 1
Mola Di Bari 1
Mountain View 1
Nagold 1
Nanchang 1
Norwalk 1
Olomouc 1
Remire-Montjoly 1
Shenyang 1
Tallinn 1
Tianjin 1
Tokyo 1
Washington 1
Totale 962
Salva come PNG Salva come JPEG
Nome #
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 101
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 101
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 84
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 81
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 75
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 72
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 64
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 58
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis 53
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 45
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 43
Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi) 42
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 42
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 38
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 34
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 31
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 27
Cartilage damage: clinical approach 27
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study 26
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 25
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 25
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 25
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 25
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 25
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 23
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 17
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 14
Complete Hydatidiform Mole Mimicking Sacroiliitis 13
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 11
Predictors of long-term clinical remission in rheumatoid arthritis 9
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 9
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 7
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 7
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 6
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 6
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 6
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 6
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 5
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 5
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 5
Letters to the editors 5
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 3
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 2
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 1
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 1
Body mass index and adipokines/cytokines dysregulation in Systemic Sclerosis 1
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE) 1
Totale 1.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201917 0 0 0 0 0 0 0 0 0 0 9 8
2019/2020234 21 5 2 15 14 29 26 32 35 23 20 12
2020/2021194 5 14 9 6 18 15 22 23 22 19 31 10
2021/2022226 9 2 5 10 9 11 25 14 17 30 32 62
2022/2023455 46 76 30 31 30 69 9 66 61 6 19 12
2023/2024177 17 45 13 19 13 41 9 6 3 7 4 0
Totale 1.332